<div dir="ltr"><div>My university (Lehigh) told faculties that we own the copyright  (which is different from IP).  But that was on scenario of teaching materials being posted by students on website such as coursehero -   the university basically said they won't help us protect these copyright and we have to protect it ourselves.  </div><div><br></div><div>Yaling</div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Tue, Jan 26, 2021 at 9:26 AM Tomas Helikar <<a href="mailto:thelikar2@unl.edu">thelikar2@unl.edu</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">

  
  <div>
    <p>Hi everyone,</p>
    <p>At our university (University of Nebraska), the university system
      retains the copyright, but the investigator is free to set up
      whatever license they want. I'm curious to see if there even is a
      university (or their tech transfer office) that would dictate
      which OS license the investigator should use.<br>
    </p>
    <p>Best,<br>
    </p>
    <div>
      <div style="line-height:16px;margin:6px 0px;padding:8px;border-top:1px dotted rgb(174,177,166);border-bottom:1px dotted rgb(174,177,166);font-size:11px;color:grey">
        <font size="2.5px;" color="#0049FF">Tomas
          Helikar, Ph.D.</font> <br>
        Associate Professor <br>
        Department of Biochemistry | University of Nebraska-Lincoln <br>
        m: <a href="callto:402-547-8904" style="color:rgb(0,136,204)" target="_blank">402-547-8904</a> | o: <a href="callto:402-472-3530" style="color:rgb(0,136,204)" target="_blank">402-472-3530</a><br>
        <a href="http://www.postbox-inc.com" style="border-bottom:1px dotted rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank">www.helikarlab.org</a> | <a href="http://helikarlab.org" style="border-bottom:1px dotted rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank">cellcollective.org</a><br>
        twitter: <a href="http://twitter.com/helikarlab" style="border-bottom:1px dotted rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank">@helikarlab</a>, <a href="http://twitter.com/biocollective" style="border-bottom:1px dotted rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank">@biocollective</a>
      </div>
    </div>
    <div>On 1/26/21 3:52 AM, Robin Thompson
      wrote:<br>
    </div>
    <blockquote type="cite">
      
      <div>
        <font face="sans-serif" color="#FF6347">Non-NU Email</font>
        <hr>
      </div>
      That sounds great, thanks both. I will let you know when I hear
      back about Oxford’s policy on commercial use of IP.  As above, all
      authors are happy with this in principle (we are grateful that
      others might want to use our models!)
      <div><br>
      </div>
      <div>Best wishes,</div>
      <div>Robin</div>
      <div><br>
        <div>
          <div dir="auto" style="color:rgb(0,0,0);letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none">
            <div dir="auto" style="color:rgb(0,0,0);letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none">
              <div>----------------------------------------------------------------------<br>
                Dr Robin Thompson<br>
                Assistant Professor of Mathematical Epidemiology<br>
                Mathematics Institute<br>
                University of Warwick, UK<br>
                <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.robin-2Dthompson.co.uk&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=N3BoKaIVANlvX-Y4BnCQHSQxKYy32mZNJ2Q9_AwX9lg&e=" target="_blank">www.robin-thompson.co.uk</a><br>
----------------------------------------------------------------------</div>
            </div>
          </div>
        </div>
        <div><br>
          <blockquote type="cite">
            <div>On 26 Jan 2021, at 00:47, Jacob Barhak <<a href="mailto:jacob.barhak@gmail.com" target="_blank">jacob.barhak@gmail.com</a>>
              wrote:</div>
            <br>
            <div>
              <div dir="ltr">Yes Sheriff,<br>
                <div><br>
                </div>
                <div>This makes sense if Robin and his
                  co-authors want to invest more time to invest in the
                  archiving process - which I support. </div>
                <div>However, the license issue needs to be
                  resolved first. You see, for anyone to release the
                  model into-biomodels they need to give away copyright
                  to release under CC0.</div>
                <div><br>
                </div>
                <div>And this is basically what I was asking -
                  what is the licensing policies the institution has?
                  For example, can the authors waive copyright in that
                  institution? </div>
                <div><br>
                </div>
                <div>If the answer is yes and I get permission,
                  I promise to upload a simplified version of one of
                  their models to Bio-Models - one that I have
                  implemented with the authors permission.</div>
                <div><br>
                </div>
                <div>This will be a nice example of what
                  should be done for models. However, this email thread
                  was intended to show the differences in approach for
                  licensing and float it up. Not all institutions allow
                  everything to creators - it varies and conditional on
                  many factors that may change. </div>
                <div><br>
                </div>
                <div>I hope it is possible.</div>
                <div><br>
                </div>
                <div>           Jacob</div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
              </div>
              <br>
              <div class="gmail_quote">
                <div dir="ltr" class="gmail_attr">On Mon, Jan 25, 2021
                  at 6:10 PM Rahuman Sheriff <<a href="mailto:sheriff@ebi.ac.uk" target="_blank">sheriff@ebi.ac.uk</a>>
                  wrote:<br>
                </div>
                <blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
                  <div>Dear
                    Robin and Jacob,
                    <div>I am happy to support, if you would
                      like the model to be deposited to BioModels
                      repository [1].</div>
                    <div>Not only the models gets higher
                      visibility, it might be potentially curated and
                      annotated and therefore can attract higher
                      citation.</div>
                    <div><br>
                    </div>
                    <div>Best regards</div>
                    <div>Sheriff</div>
                    <div><br>
                    </div>
                    <div>[1] <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__academic.oup.com_nar_article_48_D1_D407_5614569&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=QT4smRgJIXEaNNY8dtot9JqoHZHCMy6ZYNpNs6YvOaE&e=" target="_blank">https://academic.oup.com/nar/article/48/D1/D407/5614569</a><br>
                      <div><br>
                        <blockquote type="cite">
                          <div>On 24 Jan 2021, at 18:05, Robin
                            Thompson <<a href="mailto:robin.thompson1988@gmail.com" target="_blank">robin.thompson1988@gmail.com</a>>
                            wrote:</div>
                          <br>
                          <div>
                            <div>Hi Jacob,
                              <div><br>
                              </div>
                              <div>Thanks for your email. I
                                have asked the relevant person at Oxford
                                University (the institution I was at
                                when this research was undertaken), and
                                I will let you know when I hear back
                                from them.</div>
                              <div><br>
                              </div>
                              <div>Thanks, and best wishes,</div>
                              <div>Robin</div>
                              <div><br>
                                <div>
                                  <div dir="auto" style="letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none">
                                    <div dir="auto" style="letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none">
                                      <div>----------------------------------------------------------------------<br>
                                        Dr Robin Thompson<br>
                                        Assistant Professor of
                                        Mathematical Epidemiology<br>
                                        Mathematics Institute<br>
                                        University of Warwick, UK<br>
                                        <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.robin-2Dthompson.co.uk_&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=U2uKHMmBHfzYm_789nU7zyYRHmlTBaSAuEPF0wluqYo&e=" target="_blank">www.robin-thompson.co.uk</a><br>
----------------------------------------------------------------------</div>
                                    </div>
                                  </div>
                                </div>
                                <div><br>
                                  <blockquote type="cite">
                                    <div>On 22 Jan 2021, at
                                      20:37, Jacob Barhak <<a href="mailto:jacob.barhak@gmail.com" target="_blank">jacob.barhak@gmail.com</a>>
                                      wrote:</div>
                                    <br>
                                    <div>
                                      <div dir="ltr">Hi Robin,
                                        and anyone else who wants to
                                        comment, 
                                        <div>
                                          <div><br>
                                          </div>
                                          <div>When integrating
                                            your model, you may recall I
                                            asked for permissions to use
                                            it and mentioned licensing
                                            issues.</div>
                                          <div><br>
                                          </div>
                                          <div>One of your
                                            responses was that you have
                                            to check with your
                                            institution regarding
                                            commercial use while you
                                            yourself were ok with me
                                            reusing your model and had
                                            no restrictions.</div>
                                          <div><br>
                                          </div>
                                          <div>I wish to
                                            explore the licensing issue
                                            in this mailing list to show
                                            what are approaches of
                                            different institutions and
                                            individuals to the problem.</div>
                                          <div><br>
                                          </div>
                                          <div>Is it possible
                                            for you to check about the
                                            policy in your institution?
                                            The idea is to show some
                                            examples of how institutions
                                            approach the issue. For
                                            example, do they delegate
                                            the decision to researchers?
                                            Do they have a policy about
                                            who holds the copyright? How
                                            do they treat
                                            commercial entities?</div>
                                          <div><br>
                                          </div>
                                          <div>I know in the
                                            US, a faculty member in most
                                            cases retains rights for
                                            their work, this does not
                                            always extend to staff and I
                                            am not sure about students.
                                            I also know that some
                                            academic institutions
                                            support tech transfer
                                            through patents and other
                                            endeavours. </div>
                                          <div><br>
                                          </div>
                                          <div>I was trying to
                                            discuss licenses here:</div>
                                          <div><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__forum.comses.net_t_issues-2Dwith-2Dregard-2Dto-2Dcall-2Dfor-2Dtransparency-2Dof-2Dcovid-2D19-2Dmodels_8433&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=gH5csg3_h8RTAcz5uHrxGVuUx-7fyJTy-Xmq956sPAA&e=" target="_blank">https://forum.comses.net/t/issues-with-regard-to-call-for-transparency-of-covid-19-models/8433</a> </div>
                                          <div><br>
                                          </div>
                                          <div>Yet this
                                            discussion was not
                                            concluded. </div>
                                          <div><br>
                                          </div>
                                          <div>One notable
                                            approach that Sheriff made
                                            me aware of is taken by
                                            BioModels:</div>
                                          <div><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ebi.ac.uk_biomodels_faq&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=KS6kRQBfSpa4lpZQ01NJ73yFXAOeIisbWFDK911tRl8&e=" target="_blank">http://www.ebi.ac.uk/biomodels/faq</a><br>
                                          </div>
                                          <div>They avoid the
                                            licensing issues by making
                                            all models available under
                                            CC0</div>
                                          <div><br>
                                          </div>
                                          <div>I am showing
                                            here some aspects of the
                                            issue and asking for you to
                                            check with your institution
                                            to explore all aspects of
                                            this issue so we can
                                            properly report those in the
                                            white paper.</div>
                                          <div><br>
                                          </div>
                                          <div>           Jacob</div>
                                          <div><br>
                                          </div>
                                          <div><br>
                                          </div>
                                          <div><br>
                                          </div>
                                          <div><br>
                                          </div>
                                          <div><br>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </blockquote>
                                </div>
                                <br>
                              </div>
                            </div>
                          </div>
                        </blockquote>
                      </div>
                      <br>
                    </div>
                  </div>
                </blockquote>
              </div>
            </div>
          </blockquote>
        </div>
        <br>
      </div>
      <br>
      <fieldset></fieldset>
      <pre>_______________________________________________
Vp-integration-subgroup mailing list
<a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank">Vp-integration-subgroup@lists.simtk.org</a>
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=Ggyyr1Kd_CVAhkGxQBR9Svztrg7TawjjebCjTdXX_sE&e=" target="_blank">https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=Ggyyr1Kd_CVAhkGxQBR9Svztrg7TawjjebCjTdXX_sE&e=</a> 
</pre>
    </blockquote>
  </div>

_______________________________________________<br>
Vp-integration-subgroup mailing list<br>
<a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank">Vp-integration-subgroup@lists.simtk.org</a><br>
<a href="https://lists.simtk.org/mailman/listinfo/vp-integration-subgroup" rel="noreferrer" target="_blank">https://lists.simtk.org/mailman/listinfo/vp-integration-subgroup</a><br>
</blockquote></div><br clear="all"><div><br></div>-- <br><div dir="ltr" class="gmail_signature"><div dir="ltr">-- ------------------ <div>Yaling Liu, Professor </div><div>Department of Mechanical Engineering and Mechanics </div><div>Department of Bioengineering </div><div>Lehigh University </div><div><a href="http://www.lehigh.edu/~yal310" target="_blank">www.lehigh.edu/~yal310</a><br></div></div></div></div>